Archive
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA, on Tuesday, August 15, 2023, which...
Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 14, 2023. About Azenta...
Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023
Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2023. Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change 2023
Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2023 earnings which ended on June 30, 2023 on Tuesday August 8, 2023 after the market closes. The Company will host a conference call...
Azenta Announces New Biorepository in the Greater Boston Area
Azenta has selected the greater Boston area, a key pharma and biotech hub, as the next location to expand its global biorepository footprint. BURLINGTON, Mass., June 29, 2023 /PRNewswire/ --...
Azenta to Participate in the Jefferies Healthcare Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York, NY, on Thursday, June 8, 2023, which includes a...
Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery
Azenta has been Selected by the Lupus Research Alliance as its Sample Management Services Provider and Partner in Supporting the Development of the Patient Registry Component of the Lupus Nexus...
Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual B. Riley Securities Institutional Investor Conference. To attend the event please contact...
Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment
Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2023. Quarter Ended Dollars in millions, except per share data March 31, December 31, March 31,...
Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2023 earnings which ended on March 31, 2023 on Tuesday, May 9, 2023 after the market closes. The Company will host a conference call...